Terbium-161 (¹⁶¹Tb)
An emerging therapeutic radionuclide compatible with theranostic approaches. Ideal for preclinical studies and targeted radionuclide therapy development. Our secured supply chain guarantees consistent access for research partners.
(¹⁶¹Tb) emits additional Auger electrons, which may kill micrometastases better than Lutetium-177 (¹⁷⁷Lu)
Availability Production status of isotope, categorized under one of the following:
Tb-161 Routinely available: produced according to set schedules or according to current demand/requests.
For more details please contact: export@mdcr.ru
Terbium-161 (¹⁶¹Tb)
An emerging therapeutic radionuclide compatible with theranostic approaches. Ideal for preclinical studies and targeted radionuclide therapy development. Our secured supply chain guarantees consistent access for research partners.
(¹⁶¹Tb) emits additional Auger electrons, which may kill micrometastases better than Lutetium-177 (¹⁷⁷Lu)
Availability Production status of isotope, categorized under one of the following:
Tb-161 Routinely available: produced according to set schedules or according to current demand/requests.
For more details please contact: export@mdcr.ru
(¹⁶¹Tb) emits additional Auger electrons, which may kill micrometastases better than Lutetium-177 (¹⁷⁷Lu)
Availability Production status of isotope, categorized under one of the following:
Tb-161 Routinely available: produced according to set schedules or according to current demand/requests.
For more details please contact: export@mdcr.ru
Connect with us